Driving Innovation.

AI-driven drug development.
Technology

Precise connections.

Using our Guardian Angel™ Artificial Intelligence algorithm, we are precisely matching drugs to diseases and identifying the best care for individual patients. We have demonstrated the power of Guardian Angel™ by matching more than 90% of the world’s approved drugs to their indications.

Learn More
Pipeline

Life-saving drugs. Faster.

AI-driven drug development means we skip long R&D cycles, getting life-saving drugs to patients faster. Current clinical stage drug candidates target multiple orphan disorders including pulmonary sarcoidosis, bronchiolitis obliterans and amyotrophic lateral sclerosis.

Learn More
Careers

Want to join our team?